Felix John

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Global disparities in access to diagnostics and therapies for advanced non-small cell lung cancer: from discovery to delivery - a review.

Global disparities in access to diagnostics and therapies for advanced non-small cell lung cancer: from discovery to delivery - a review.

Journal: Frontiers in oncology
Published: February 09, 2026

Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.

Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 12, 2026

Response to Trastuzumab Deruxtecan in a Patient With EGFR-Mutated NSCLC and Transformation to SCLC Harboring HER2 Amplification: A Case Report.

Response to Trastuzumab Deruxtecan in a Patient With EGFR-Mutated NSCLC and Transformation to SCLC Harboring HER2 Amplification: A Case Report.

Journal: JTO clinical and research reports
Published: October 29, 2025

Treatment of metastatic non-small cell lung cancer

Treatment of metastatic non-small cell lung cancer

Journal: Innere Medizin (Heidelberg, Germany)
Published: August 11, 2025

MET-Driven Resistance to Sotorasib in KRAS G12C-Mutant NSCLC and Response to Combined KRAS and MET Inhibition.

MET-Driven Resistance to Sotorasib in KRAS G12C-Mutant NSCLC and Response to Combined KRAS and MET Inhibition.

Journal: JTO clinical and research reports
Published: July 30, 2025

Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.

Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 17, 2025

Evaluating docetaxel effectiveness in KRAS G12C-mutated NSCLC: insights from a Real-World cohort.

Evaluating docetaxel effectiveness in KRAS G12C-mutated NSCLC: insights from a Real-World cohort.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 22, 2025

Advances in the targeted treatment of non-small cell lung cancer

Advances in the targeted treatment of non-small cell lung cancer

Journal: Innere Medizin (Heidelberg, Germany)
Published: December 14, 2023

MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.

MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 25, 2023

Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients.

Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 06, 2023

Evolutionary trajectories of small cell lung cancer under therapy.

Evolutionary trajectories of small cell lung cancer under therapy.

Journal: Nature
Published: January 25, 2023

ROS scavengers decrease γH2ax spots in motor neuronal nuclei of ALS model mice in vitro.

ROS scavengers decrease γH2ax spots in motor neuronal nuclei of ALS model mice in vitro.

Journal: Frontiers in cellular neuroscience
Published: June 07, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026